JP2004526702A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004526702A5 JP2004526702A5 JP2002562379A JP2002562379A JP2004526702A5 JP 2004526702 A5 JP2004526702 A5 JP 2004526702A5 JP 2002562379 A JP2002562379 A JP 2002562379A JP 2002562379 A JP2002562379 A JP 2002562379A JP 2004526702 A5 JP2004526702 A5 JP 2004526702A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkoxy
- ile
- residue derived
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10105038A DE10105038B4 (de) | 2001-02-05 | 2001-02-05 | Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems |
| PCT/EP2002/001183 WO2002062373A2 (en) | 2001-02-05 | 2002-02-05 | Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004526702A JP2004526702A (ja) | 2004-09-02 |
| JP2004526702A5 true JP2004526702A5 (cg-RX-API-DMAC7.html) | 2005-12-22 |
| JP4183507B2 JP4183507B2 (ja) | 2008-11-19 |
Family
ID=7672831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002562379A Expired - Fee Related JP4183507B2 (ja) | 2001-02-05 | 2002-02-05 | 神経系の損傷後疾患の処置のためのトリペプチド及びトリペプチド誘導体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7122524B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1363656B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4183507B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE285244T1 (cg-RX-API-DMAC7.html) |
| DE (2) | DE10105038B4 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2230480T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1363656E (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002062373A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10105038B4 (de) | 2001-02-05 | 2005-07-07 | Neurotell Ag | Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems |
| DE10105041A1 (de) | 2001-02-05 | 2002-08-14 | Tell Pharm Ag Hergiswil | Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten |
| DE10105040A1 (de) | 2001-02-05 | 2002-08-14 | Tell Pharm Ag Hergiswil | Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems |
| JP2011201923A (ja) * | 2005-07-01 | 2011-10-13 | Snow Brand Milk Products Co Ltd | ジペプチジルペプチダーゼｉｖ阻害剤 |
| CN106317177A (zh) * | 2015-06-23 | 2017-01-11 | 首都医科大学 | Gly-Phe-Pro,其合成,活性和应用 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1323301C (en) * | 1987-06-05 | 1993-10-19 | Alan I. Faden | Thyrotropin-releasing hormone analogs in cns injury |
| FR2622581B1 (fr) * | 1987-11-03 | 1990-02-16 | Inorgan Sa Rech Develop Pharm | Nouveaux derives de l-proline, leur preparation et leurs applications biologiques |
| EP0445606B1 (en) * | 1990-02-27 | 1997-01-22 | The Agency of Industrial Science and Technology | Novel oligopeptides, pharmaceutical composition and food containing the same, and use of oligopeptides |
| DE4007869A1 (de) | 1990-03-13 | 1991-09-19 | Merck Patent Gmbh | Aminosaeurederivate |
| JPH045240A (ja) | 1990-04-20 | 1992-01-09 | Taisho Pharmaceut Co Ltd | 抗痴呆剤 |
| US5091391A (en) * | 1990-08-16 | 1992-02-25 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Method of resisting neurodegenerative disorders |
| JPH06504061A (ja) | 1990-12-28 | 1994-05-12 | コーテックス ファーマシューティカルズ インコーポレイテッド | 神経変性の治療および予防におけるカルパイン阻害剤の使用 |
| WO1992013549A1 (en) * | 1991-02-07 | 1992-08-20 | Research Corporation Technologies, Inc. | Inhibition of cell proliferation by hydrophobic peptides |
| US6235929B1 (en) | 1991-12-27 | 2001-05-22 | Georgia Tech Research Corporation | Tripeptide α-ketoamides |
| ZA95260B (en) * | 1994-01-13 | 1995-09-28 | Univ Columbia | Synthetic receptors libraries and uses thereof |
| US5716929A (en) | 1994-06-17 | 1998-02-10 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
| US5834029A (en) | 1994-07-20 | 1998-11-10 | Cytotherapeutics, Inc. | Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment |
| JPH0940577A (ja) * | 1995-05-24 | 1997-02-10 | Mitsui Toatsu Chem Inc | トリペプチド、ジペプチドを含有する医薬組成物 |
| EP0840614A1 (en) | 1995-06-13 | 1998-05-13 | Sanofi Winthrop, Inc. | Calpain inhibitors for the treatment of neurodegenerative diseases |
| JPH09169797A (ja) * | 1995-12-22 | 1997-06-30 | Mitsui Toatsu Chem Inc | プロテアーゼアクティベーター活性を有するペプチド |
| US5840838A (en) * | 1996-02-29 | 1998-11-24 | University Of Kentucky Research Foundation | Process for enhancing the activity of amyloid β peptides |
| JP2001501930A (ja) * | 1996-10-04 | 2001-02-13 | オークランド ユニサーヴィスィズ リミテッド | 神経酵素の調節 |
| JP4727770B2 (ja) | 1997-09-26 | 2011-07-20 | カルピス株式会社 | 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤 |
| US6080848A (en) * | 1998-05-01 | 2000-06-27 | Incyte Pharmaceuticals, Inc. | Human brain associated protein |
| US6379691B1 (en) * | 1998-09-29 | 2002-04-30 | Medtronic/Ave, Inc. | Uses for medical devices having a lubricious, nitric oxide-releasing coating |
| AU1574701A (en) * | 1999-10-22 | 2001-04-30 | Wrair Walter Reed Army Institute Of Research | A pharmaceutical composition containing pglu-glu-pro-nh2 and method for treating diseases and injuries to the brain, spinal cord and retina using same |
| JP4633876B2 (ja) | 1999-11-11 | 2011-02-16 | カルピス株式会社 | トリペプチドの製造方法 |
| WO2001068114A1 (en) | 2000-03-10 | 2001-09-20 | Monsanto Company | Novel peptides with anti-hypertensive activity |
| DE10105041A1 (de) | 2001-02-05 | 2002-08-14 | Tell Pharm Ag Hergiswil | Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten |
| DE10105038B4 (de) | 2001-02-05 | 2005-07-07 | Neurotell Ag | Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems |
| US6846641B2 (en) * | 2002-04-23 | 2005-01-25 | Agy Therapeutics, Inc. | In vitro ischemia model |
-
2001
- 2001-02-05 DE DE10105038A patent/DE10105038B4/de not_active Expired - Fee Related
-
2002
- 2002-02-05 PT PT02719767T patent/PT1363656E/pt unknown
- 2002-02-05 EP EP02719767A patent/EP1363656B1/en not_active Expired - Lifetime
- 2002-02-05 JP JP2002562379A patent/JP4183507B2/ja not_active Expired - Fee Related
- 2002-02-05 WO PCT/EP2002/001183 patent/WO2002062373A2/en not_active Ceased
- 2002-02-05 ES ES02719767T patent/ES2230480T3/es not_active Expired - Lifetime
- 2002-02-05 AT AT02719767T patent/ATE285244T1/de not_active IP Right Cessation
- 2002-02-05 DE DE60202356T patent/DE60202356T2/de not_active Expired - Lifetime
-
2003
- 2003-08-05 US US10/635,805 patent/US7122524B2/en not_active Expired - Fee Related